The number of ALS cases in the U.S. is expected to increase by over 10% by 2030, as compared with 2022 prevalence rates, per ...

After columnist Dagmar Munn was diagnosed with ALS, she began setting an intention for the new year instead of formal resolutions.

Neurosense entered a binding term sheet with a global pharmaceutical company to advance development and commercialization of ...